Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

It doesn't matter whether Provista cancelled that agreement or not. DR-70 is now off patent. Without patent protection that agreement is worthless.

Assume that this Provista 5-year agreement was never cancelled and assume that you want to manufacture and sell DR-70 today. Nobody has protected intellectual property to take into court and stop you.

Nobody can stop Gartner from doing this at GCDx either.

The problem is.... DR-70 has failed to turn a profit since Radient first tried marketing it in Brazil in 1995. IMO, the test isn't getting better or more relevant with age -- it's getting more obsolete.